Changes in blood coagulation-fibrinolysis markers by pneumatic tourniquet during total knee joint arthroplasty with venous thromboembolism

Journal of Arthroplasty

Volumn 29, Issue 3, 2014, Pages 569-573

  Watanabe, Hideaki ^a   Kikkawa, Ichiro ^a   Madoiwa, Seiji ^a   Sekiya, Hitoshi ^a   Hayasaka, Shinya ^b   Sakata, Yoichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b DAITO BUNKA UNIVERSITY   (Japan)

Author keywords

Cross linked fibrin degradation products by leukocyte elastase (e XDP); D dimer; Plasminogen activator inhibitor type 1; Soluble fibrin monomer complex; Total knee arthroplasty; Venous thromboembolism

Indexed keywords

CROSS-LINKED FIBRIN DEGRADATION PRODUCTS BY LEUKOCYTE ELASTASE (E-XDP); D-DIMER; PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1; SOLUBLE FIBRIN MONOMER COMPLEX; TOTAL KNEE ARTHROPLASTY; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ARTHRITIS; ARTHROPLASTY, REPLACEMENT, KNEE; BIOLOGICAL MARKERS; BLOOD COAGULATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PLASMINOGEN ACTIVATOR INHIBITOR 1; TOURNIQUETS; VENOUS THROMBOEMBOLISM;

EID: 84893876618     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2013.08.011     Document Type: Article

References (27)

1. Berend K.R., Lombardi A.V. Multimodal venous thromboembolic disease prevention for patients undergoing primary or revision total joint arthroplasty: the role of aspirin. Am J Orthop 2006, 35:24.
2. Howie C., Hughes H., Watts A.C. Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population study. J Bone Joint Surg Br 2005, 87:1675.
3. Soohoo N.F., Zingmond D.S., Lieberman J.R., et al. Primary total knee arthroplasty in California 1991 to 2001: does hospital volume affect outcomes?. J Arthroplasty 2006, 21:199.
4. Geerts W.H., Heit J.A., Clagett G.P., et al. Prevention of venous thromboembolism. Chest 2001, 119:132S.
5. Park K.H., Cheon S.H., Lee J.H., et al. Incidence of venous thromboembolism using 64 channel multidetector row computed tomography indirect venography and anticoagulation therapy after total knee arthroplasty in Korea. Knee Surg Relat Res 2012, 24:19.
6. Watanabe H., Sekiya H., Kariya Y., et al. The incidence of venous thromboembolism before and after total knee arthroplasty using 16-row multidetector computed tomography. J Arthroplasty 2011, 26:1488.
7. Sharrock N.E., Gonzalez Della Valle A., Go G., et al. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res 2008, 466:714.
8. Saleh K., Olson M., Resig S., et al. Predictors of wound infection in hip and knee joint replacement: results from a 20year surveillance program. J Orthop Res 2002, 20:506.
9. Parvizi J., Ghanem E., Joshi A., et al. Does "excessive" anticoagulation predispose to periprosthetic infection?. J Arthroplasty 2007, 22:24.
10. Burnett R.S., Clohisy J.C., Wright R.W., et al. Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty 2007, 22:317.
11. Saxena A., Baratz M., Austin M.S., et al. Periprosthetic joint infection can cause abnormal systemic coagulation. J Arthroplasty 2011, 26:50.
12. Cho K.Y., Kim K.I., Khurana S., et al. Is routine chemoprophylaxis necessary for prevention of venous thromboembolism following knee arthroplasty in a low incidence population?. Arch Orthop Trauma Surg 2013, 133:551.
13. Abunasser J., Tejada J.P., Foley R.J. The diagnosis and management of pulmonary embolism. Conn Med 2012, 76:5.
14. Katsumata S., Nagashima M., Kato K., et al. Changes in coagulation-fibrinolysis marker and neutrophil elastase following the use of tourniquet during total knee arthroplasty and the influence of neutrophil elastase on thromboembolism. Acta Anaesthesiol Scand 2005, 49:510.
15. Nishiguchi M., Takamura N., Abe Y., et al. Pilot study on the use of tourniquet: a risk factor for pulmonary thromboembolism after total knee arthroplasty?. Thromb Res 2005, 115:271.
16. Kageyama K., Nakajima Y., Shibasaki M., et al. Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty. J Thromb Haemost 2007, 5:738.
17. Reikeras O., Clementsen T. Time course of the thrombosis and fibrinolysis in total knee arthroplasty with tourniquet application. Local versus systemic activations. J Thromb Thrombolysis 2009, 28:425.
18. Editorial Committee on Japanese guideline for prevention of venous thromboembolism: digest. 2nd ed. Medical Front International Limited, Tokyo, 2004; p. 15-6.
19. Warwick D., Friedman R.J., Agnelli G., et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg Br 2007, 89:799.
20. Ono T., Sogabe M., Ogura M., et al. Automated latex photometric immunoassay for total plasminogen activator inhibitor-1 in plasma. Clin Chem 2003, 49:987.
21. Soe G., Kohno I., Inuzuka K., et al. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma. Blood 1996, 88:2109.
22. Matsuda M, Terukina S, Yamazumi K, Maekawa H, Soe G. A monoclonal antibody that recognizes the NH2-terminal conformation of fragment D. p. 43-8. In: Fibrinogen 4, current basic and clinical aspects: proceedings of the International Fibrinogen Workshop, Kyoto, Japan, 27-28 August 1989. Amsterdam: Excerpta Medica; 1990: 43-8.
23. Kohno I., Inuzuka K., Itoh Y., et al. A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma. Blood 2000, 95:1721.
24. Bounameaux H., Miron M.J., Blanchard J., et al. Measurement of plasma d-dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty. Blood Coagul Fibrinolysis 1998, 9:749.
25. Rever G., Blanchard J., Bounameaux H., et al. Inability of serial fibrin monomer measurements to predict or exclude deep venous thrombosis in asymptomatic patients undergoing total knee arthroplasty. Blood Coagul Fibrinolysis 2000, 11:305.
26. Watanabe H., Madoiwa S., Sekiya S., et al. Predictive blood coagulation markers for early diagnosis of venous thromboembolism after total knee joint replacement. Thromb Res 2011, 128:e137.
27. Yukizawa Y., Inaba Y., Watanabe S., et al. Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty. Acta Orthop 2012, 83:14.